[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (140)

Search Parameters:
Keywords = haemolysis

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
24 pages, 4202 KiB  
Article
In Vitro, In Vivo, Ex Vivo Characterisation of Dihydroimidazotriazinones and Their Thermal Decomposition Course Studied by Coupled and Simultaneous Thermal Analysis Methods
by Marta Worzakowska, Małgorzata Sztanke, Jolanta Rzymowska and Krzysztof Sztanke
Int. J. Mol. Sci. 2025, 26(2), 541; https://doi.org/10.3390/ijms26020541 - 10 Jan 2025
Viewed by 244
Abstract
The biological and thermal properties of a class of synthetic dihydroimidazotriazinones were disclosed in this article for the first time. Molecules 16—as potential innovative antimetabolites mimicking bicyclic aza-analogues of isocytosine—were evaluated for their in vitro anticancer activity. Moreover, in vivo, [...] Read more.
The biological and thermal properties of a class of synthetic dihydroimidazotriazinones were disclosed in this article for the first time. Molecules 16—as potential innovative antimetabolites mimicking bicyclic aza-analogues of isocytosine—were evaluated for their in vitro anticancer activity. Moreover, in vivo, in vitro, and ex vivo toxicity profiles of all the compounds were established in zebrafish, non-tumour cell, and erythrocyte models, respectively. Their antihaemolytic activity was also evaluated. Additionally, the thermal decomposition mechanism, path, and key thermal properties of heterocycles 16 were analysed. It was found that all the studied compounds revealed significant antiproliferative activities against tumour cells of the lung, cervix, ovary, and breast, as well as acute promyelocytic leukaemia cells, superior or comparable to that of an anticancer agent gemcitabine. Most of them were less toxic to non-tumour cells than this standard drug, and none had a haemolytic effect on red blood cells. All the tested heterocycles proved to be safer for zebrafish than a standard drug pemetrexed. Some exhibited the ability to inhibit oxidative haemolysis, suggesting their protective action on erythrocytes. The differential scanning calorimetry (DSC) analyses confirmed that all molecules melted within one narrow temperature range, proving their purity. The melting points depended solely on the type of substituent and increased as follows: 4 (R = 3-ClPh) < 2 (R = 4-CH3Ph) = 3 (R = 4-OCH3Ph) < 5 (R = 4-ClPh) = 1 (R = Ph) < 6 (R = 3,4-Cl2Ph). The thermogravimetry/differential thermogravimetry (TG/DTG) studies confirmed high thermal stability of all the investigated heterocycles in inert (>230 °C) and oxidising (>260 °C) atmospheres, which depended directly on the R. The pyrolysis process included one main decomposition stage and was connected with the emission of NH3, HCN, CH3CN, HNCO, alkane, alkene, aromatic fragments, CO2 (for all the compounds), and HCl (for the molecule with 3,4-Cl2Ph), which was confirmed by FTIR and QMS analyses. In turn, the oxidative decomposition process of the tested polyazaheterocycles took place in two main stages connected with the formation of the same volatiles as those observed in an inert atmosphere and additionally with the release of N2, NO, CO, and H2O. These results proved that the pyrolysis and oxidative decomposition run through the radical mechanism connected with the additional reactions between radicals and oxygen in synthetic air. The favourable biological and thermal properties of this class of dihydroimidazotriazinones imply their usefulness as potential pharmaceutics. Full article
(This article belongs to the Section Molecular Biology)
Show Figures

Figure 1

Figure 1
<p>Structures of the investigated compounds: <b>1</b>. R = Ph; <b>2.</b> R = 4-CH<sub>3</sub>Ph; <b>3</b>. R = 4-OCH<sub>3</sub>Ph; <b>4</b>. R = 3-ClPh; <b>5.</b> R = 4-ClPh; <b>6</b>. R = 3,4-Cl<sub>2</sub>Ph.</p>
Full article ">Figure 2
<p>Zebrafish mortality in the control and compound/standard drug-treated groups at the end of the exposure period. STD—a standard drug pemetrexed. Data represent the mean ± SD of three independent experiments under similar conditions. *—statistically different from the control group (<span class="html-italic">p</span> &lt; 0.05, Student’s <span class="html-italic">t</span>-test).</p>
Full article ">Figure 3
<p>Hatching rates of zebrafish embryos in the control and compound/standard drug-treated groups. STD—a standard drug pemetrexed. hpf—hours post-fertilisation.</p>
Full article ">Figure 4
<p>Cardiac function measured by heartbeats per minute in zebrafish exposed to the tested compounds/standard drug. STD—a standard drug pemetrexed. Data represent the mean ± SD of three independent experiments under similar conditions. *—statistically different from the control group (<span class="html-italic">p</span> &lt; 0.05, Student’s <span class="html-italic">t</span>-test).</p>
Full article ">Figure 5
<p>The representative 96 h old larvae from the control group and groups exposed to the highest concentration of compound/standard drug that did not induce phenotypic abnormalities.</p>
Full article ">Figure 6
<p>Phenotypic abnormalities (yolk sac swelling, pericardial oedema, and abnormal body shape) observed in 96 h old larvae treated with compounds <b>1</b>–<b>6</b> and the standard drug.</p>
Full article ">Figure 7
<p>DSC curves for the tested compounds collected in an inert atmosphere.</p>
Full article ">Figure 8
<p>TG (<b>a</b>) and DTG (<b>b</b>) curves for the tested compounds in inert conditions.</p>
Full article ">Figure 9
<p>The gaseous FTIR spectra collected at <span class="html-italic">T</span><sub>max1</sub> in inert conditions.</p>
Full article ">Figure 10
<p>The gaseous QMS spectra collected at <span class="html-italic">T</span><sub>max1</sub> in inert conditions.</p>
Full article ">Figure 11
<p>TG (<b>a</b>) and DTG (<b>b</b>) curves for the tested compounds in oxidising conditions.</p>
Full article ">Figure 12
<p>The gaseous FTIR spectra collected at <span class="html-italic">T</span><sub>max1</sub> and <span class="html-italic">T</span><sub>max2</sub>.</p>
Full article ">Figure 13
<p>The exemplary QMS spectra collected at <span class="html-italic">T</span><sub>max1</sub> (<b>a</b>) and <span class="html-italic">T</span><sub>max2</sub> (<b>b</b>) (for compound <b>2</b>) in oxidising conditions.</p>
Full article ">Scheme 1
<p>The course of pyrolysis of the tested compounds in inert conditions.</p>
Full article ">
16 pages, 5763 KiB  
Article
Anti-Inflammatory Potential and Synergic Activities of Eclipta prostrata (L.) L. Leaf-Derived Ointment Formulation in Combination with the Non-Steroidal Anti-Inflammatory Drug Diclofenac in Suppressing Atopic Dermatitis (AD)
by Muhammad M. Poyil, Mohammed H. Karrar Alsharif, Mahmoud H. El-Bidawy, Salman Bin Dayel, Mohammed Sarosh Khan, Zainab Mohammed M. Omar, Alaaeldin Ahmed Mohamed, Reda M. Fayyad, Tarig Gasim Mohamed Alarabi, Hesham A. Khairy, Nasraddin Othman Bahakim, Mohamed A. Samhan and Abd El-Lateef Saeed Abd El-Lateef
Life 2025, 15(1), 35; https://doi.org/10.3390/life15010035 - 30 Dec 2024
Viewed by 447
Abstract
Atopic dermatitis (AD) or eczema is an important inflammatory chronic skin disease that brings many complications in its management and treatment. Although several chemical agents are used for treatment, the search for better anti-inflammatory and antibacterial agents of plant origin has been ongoing, [...] Read more.
Atopic dermatitis (AD) or eczema is an important inflammatory chronic skin disease that brings many complications in its management and treatment. Although several chemical agents are used for treatment, the search for better anti-inflammatory and antibacterial agents of plant origin has been ongoing, since natural compounds, it is commonly believed, are less dangerous than synthetic ones. Therefore, the present study explored a medicinal plant—Eclipta prostrata (L.) L.—for its anti-inflammatory activity alone and in combination with a non-steroidal anti-inflammatory drug (NSAID), diclofenac. The plant extract was used to make a cream formulation for treating atopic dermatitis and as an antibacterial agent against Staphylococcus aures, the major infectious agent associated with AD. The phytochemical analysis of the E. prostrata extract showed the presence of various phytochemicals, including flavonoids, Tannin, saponin, terpenoids, glycosides, phenol, alkaloids, quinone, and protein. The GC-MS profiling of methanolic E. prostrata extract was performed predicted the presence of twenty important phytochemicals, including 2-[5-(2-Hydroxypropyl) oxolan-2-yl]propanoic acid, dl-Menthol, dodecane, undecane, 4,7-dimethyl-, dodecane, 2,6,10-trimethyl-, decane, 2,3,5,8-tetramethyl-, cholest-5-en-3-ol, (3.alpha.)-, TMS derivative, cyclopropane carboxylic acid, 1-hydroxy-, (2,6-di-t-butyl-4-methylphenyl) ester, alpha.-farnesene, propanoic acid, 2-methyl-, 2-ethyl-1-propyl-1,3-propanediyl ester, diethyl phthalate, corticosterone, 2-methylpropionate, hentriacontan-13-ol, O-TMS, phthalic acid, 2,4-dimethylpent-3-yl dodecyl ester, hexasiloxane, 1,1,3,3,5,5,7,7,9,9,11,11-dodecamethyl-, acetic acid, 4-t-butyl-4-hydroxy-1,5-dimethyl-hex-2-ynyl ester, octadecane, 2-methyl- octacosane, 1-iodo-, nonacosane, and eicosyl isopropyl ether. Using an egg albumin denaturation inhibition assay, the anti-inflammatory activities of E. prostrata alone and in combination with diclofenac were investigated, and they showed 93% and 99% denaturation inhibition at 5 mg concentration of E. prostrata in alone and combination with diclofenac, respectively. Heat-induced haemolysis showed 2.5% and 2.4% of haemolysis at 5 mg of E. prostrata alone and in combination with diclofenac, respectively. An MTT assay performed using L929 cells proved that the extract has no cytotoxic effect. The plant extract displayed potential antibacterial activity against Staphylococcus aureus; the growth was inhibited at 1 mg/mL of E. prostrata extract. Thus, based on this evidence, the authors suggest that E. prostrata extract should be studied further for its anti-inflammatory and antibacterial activities and topical application in the treatment of atopic dermatitis. Full article
Show Figures

Figure 1

Figure 1
<p>GC-MS chemical profiling of <span class="html-italic">E. prostrata</span> in methanolic fraction. TIC = tentatively identified compounds); min = minutes.</p>
Full article ">Figure 2
<p>Inhibition percentage of <span class="html-italic">E. prostrata</span> methanolic extract alone and in combination with diclofenac on egg albumin denaturation. EP = <span class="html-italic">E. prostrata,</span> EP + D = <span class="html-italic">E. prostrata</span> + diclofenac.</p>
Full article ">Figure 3
<p>Heat-inducing hemolysishaemolysis percentage of <span class="html-italic">E. prostrata</span> methanolic extract alone and in combination with diclofenac. EP = <span class="html-italic">E. prostrata,</span> EP + D = <span class="html-italic">E. prostrata</span> + diclofenac.</p>
Full article ">Figure 4
<p><span class="html-italic">E. prostrata</span> 15% methanolic extract cream effect on human skin prepared.</p>
Full article ">Figure 5
<p>Cell viability percentage of <span class="html-italic">E. prostrata</span> methanolic extract after treating L<sub>929</sub> cells using MTT assay. (<b>A</b>) Untreated L<sub>929</sub> cell morphology. (<b>B</b>) L<sub>929</sub> cell morphology after treatment with <span class="html-italic">E. prostrata</span>. (<b>C</b>) The graph represents the percentage of cell viability after treatment.</p>
Full article ">Figure 6
<p><span class="html-italic">E. prostrata</span> methanolic extract antibacterial activity against <span class="html-italic">S. aureus.</span> Two different concentrations exhibited inhibition zones around the well. Note: P—positive control (tetracycline) and v—vehicle control.</p>
Full article ">Figure 7
<p><span class="html-italic">E. prostrata</span> methanolic extract MIC was determined against <span class="html-italic">S. aureus</span>, and the growth inhibition was noted at 1 mg/mL.</p>
Full article ">
16 pages, 6273 KiB  
Review
Recent Advances and Future Directions in Extracorporeal Carbon Dioxide Removal
by Tomás Lamas, Susana M. Fernandes, Francesco Vasques, Christian Karagiannidis, Luigi Camporota and Nicholas Barrett
J. Clin. Med. 2025, 14(1), 12; https://doi.org/10.3390/jcm14010012 - 24 Dec 2024
Viewed by 566
Abstract
Extracorporeal carbon dioxide removal (ECCO2R) is an emerging technique designed to reduce carbon dioxide (CO2) levels in venous blood while enabling lung-protective ventilation or alleviating the work of breathing. Unlike high-flow extracorporeal membrane oxygenation (ECMO), ECCO2R operates [...] Read more.
Extracorporeal carbon dioxide removal (ECCO2R) is an emerging technique designed to reduce carbon dioxide (CO2) levels in venous blood while enabling lung-protective ventilation or alleviating the work of breathing. Unlike high-flow extracorporeal membrane oxygenation (ECMO), ECCO2R operates at lower blood flows (0.4–1.5 L/min), making it less invasive, with smaller cannulas and simpler devices. Despite encouraging results in controlling respiratory acidosis, its broader adoption is hindered by complications, including haemolysis, thrombosis, and bleeding. Technological advances, including enhanced membrane design, gas exchange efficiency, and anticoagulation strategies, are essential to improving safety and efficacy. Innovations such as wearable prototypes that adapt CO2 removal to patient activity and catheter-based systems for lower blood flow are expanding the potential applications of ECCO2R, including as a bridge-to-lung transplantation and in outpatient settings. Promising experimental approaches include respiratory dialysis, carbonic anhydrase-coated membranes, and electrodialysis to maximise CO2 removal. Further research is needed to optimise device performance, develop cost-effective systems, and establish standardised protocols for safe clinical implementation. As the technology matures, integration with artificial intelligence (AI) and machine learning may personalise therapy, improving outcomes. Ongoing clinical trials will be pivotal in addressing these challenges, ultimately enhancing the role of ECCO2R in critical care and its accessibility across healthcare settings. Full article
(This article belongs to the Special Issue New Advances in Extracorporeal Membrane Oxygenation (ECMO))
Show Figures

Figure 1

Figure 1
<p>Example of different blood washouts depending on high and low blood flows in membrane oxygenator with impact on anticoagulation requirements to prevent membrane clotting. Pictures kindly provided by F. Hesselmann and R. Borchardt, Aachen, Germany.</p>
Full article ">Figure 2
<p>Fibre arrangement in parallel plate and circular membrane lungs (ML). In the circular ML, blood flow is nearly antiparallel to the gas fibres and flow. In the lower part of the ML, where blood enters, blood encounters sweep gas with the highest CO<sub>2</sub> concentration. Since CO<sub>2</sub> removal depends on the diffusion gradient between the gas and blood—small in this region—CO<sub>2</sub> clearance is inefficient here. In the parallel-plate MLs, blood flows perpendicularly to the gas fibres. Similarly, at the lower part of the ML, where blood interacts with gas containing the highest CO<sub>2</sub> levels, CO<sub>2</sub> removal is less effective. With permission from Schwärzel et al. [<a href="#B80-jcm-14-00012" class="html-bibr">80</a>].</p>
Full article ">Figure 3
<p>The proportion of carbamino form contribution from arterial CO<sub>2</sub> content to venous CO<sub>2</sub> content is significantly higher than the other forms of CO<sub>2</sub> content due to the Haldane effect (increasing haemoglobin affinity to CO<sub>2</sub> in lower oxygen concentration). The CO<sub>2</sub> removal of the gaseous phase of CO<sub>2</sub> represents only a small fraction of total CO<sub>2</sub> content. The bicarbonate removal using zero bicarbonate dialytic solution through haemofilter could contribute to significantly higher CO<sub>2</sub> removal of total CO<sub>2</sub> content. However, the blood buffer must be replaced by other natural buffers to maintain the acid–base equilibrium.</p>
Full article ">
23 pages, 2539 KiB  
Article
Chemical and Biological Properties of Different Romanian Populations of Hyssopus officinalis Correlated via Molecular Docking
by Ilinca Merima Imbrea, Magdalena Osiceanu, Anca Hulea, Mukhtar Adeiza Suleiman, Iuliana Popescu, Doris Floares (Oarga), Emilian Onisan, Alina-Georgeta Neacșu, Cosmin Alin Popescu, Calin Hulea, Georgeta Pop, Simona Niță, Florin Imbrea and Diana Obistioiu
Plants 2024, 13(22), 3259; https://doi.org/10.3390/plants13223259 - 20 Nov 2024
Viewed by 646
Abstract
This study compares three Romanian Hyssopus officinalis species—H. officinalis f. ruber (HOR), H. officinalis f. albus (HOA), and H. officinalis f. cyaneus (HOC)—evaluating their chemical composition and biological activities, specifically protein denaturation, haemolysis inhibition, and antibacterial effects. Chemical profiles were determined using [...] Read more.
This study compares three Romanian Hyssopus officinalis species—H. officinalis f. ruber (HOR), H. officinalis f. albus (HOA), and H. officinalis f. cyaneus (HOC)—evaluating their chemical composition and biological activities, specifically protein denaturation, haemolysis inhibition, and antibacterial effects. Chemical profiles were determined using Gas Chromatography–Mass Spectrometry (GC-MS). The species were cultivated at two distinct locations: the Didactic and Experimental Station DESUSVT and the Agricultural Research and Development Station Lovrin (ARDSL). This study investigates the correlation between chemical composition, biological activities, and local climate data at each site. The results show significant variations in chemical profiles, with species and cultivation location influencing the biological activities. H. officinalis f. albus (HOA) exhibited the strongest antimicrobial activity, particularly against Gram-positive bacteria. The molecular docking analysis highlighted key compounds, such as cyclohexene,4-isopropenyl-1-methoxymethoxymethyl and elemol, with binding solid affinities to microbial and inflammatory proteins. This study provides valuable insights into the chemical and biological properties of Hyssopus officinalis, emphasising its potential in combating microbial infections, protein denaturation, and haemolysis inhibition. Full article
(This article belongs to the Special Issue Chemical Analysis, Bioactivity, and Application of Essential Oils)
Show Figures

Figure 1

Figure 1
<p>The Pearson correlation matrix for soil physical and chemical characteristics in Timișoara and Lovrin and the influence of oil yield extraction traits.</p>
Full article ">Figure 2
<p>The heatmap of Pearson correlation coefficients for chemical composition by variety and location.</p>
Full article ">Figure 3
<p>(<b>A</b>) The scree plot of P.C.A.; (<b>B</b>) the biplot of P.C.A.; (<b>C</b>) the contribution of variables to the first dimension of P.C.A.; (<b>D</b>) the contribution of variables to the second dimension of P.C.A. Note: V1: α-Pinene, V2: α-Phellandrene, V3: β-Pinene, V4: Sabinene, V5: β-Myrcene, V6: Limonene, V7: β-Phellandrene, V8: <span class="html-italic">β-cis</span>-Ocimene, V9: Eucalyptol, V10: cyclohexene, 4-isopropenyl-1-methoxymethoxymethyl-, V11: α-Gurjunene, V12: β-Bourbonene, V13: linalool, V14: 3-Thujanone, V15: Caryophyllene, V16: Alloaromadendrene, V17: Humulene, V18: α-Caryophyllene, V19: γ-Cadinene, V20: Pinocamphone, V21: germacrene d, V22: Isocamphopinone, V23: γ-Elemene, V24: Estragole, V25: 3-octen-5-yne, 2,7-dimethyl-, (e)-, V26: p-menth-1-en-8-ol, V27: (1r)-(−)-Myrtenal, V28: myrtenol, V29: Ledol, V30: elemol, V31: Eugenol methyl ether, V32: Caryophyllene oxide, V33: (−)-Spathulenol.</p>
Full article ">Figure 4
<p>Three-dimensional (3D) and two-dimensional (2D) structural best binding modes between the antimicrobial, anti-inflammatory proteins and the identified compounds of the Hyssopus plants.</p>
Full article ">
16 pages, 2568 KiB  
Article
Designing Analogs of SAAP-148 with Enhanced Antimicrobial and Anti-LPS Activities
by Lingmin Gan, Yulang Chi, Yunhui Peng, Subo Li, Hongwei Gao, Xue Zhang, Shouping Ji, Zili Feng and Shikun Zhang
Int. J. Mol. Sci. 2024, 25(21), 11776; https://doi.org/10.3390/ijms252111776 - 1 Nov 2024
Viewed by 940
Abstract
SAAP-148, a derivative of LL-37, exhibits a well-defined amphipathic structure and enhanced antimicrobial activity; however, it also displays significant cytotoxicity towards human cells. In this study, we employed Lys-scan to produce a series of amphiphilic SAAP-148 analogs derived from the SAAP-148 sequence to [...] Read more.
SAAP-148, a derivative of LL-37, exhibits a well-defined amphipathic structure and enhanced antimicrobial activity; however, it also displays significant cytotoxicity towards human cells. In this study, we employed Lys-scan to produce a series of amphiphilic SAAP-148 analogs derived from the SAAP-148 sequence to investigate the impact of the distribution of positively charged residues on the biological viability of the antimicrobial peptides (AMPs). The physical properties and biological activity of the designed peptides were subsequently compared. The substitution of lysine resulted in an increase in the overall charge of SAAP-148 and a decrease in its overall hydrophobicity and hyd. moment, except for SAAP-10 where an analogue substitution occurred at the 18th residue. The replacement of lysine led to a reduction in hemolytic activity compared to SAAP-148, with slightly higher haemolysis rates observed in SAAP-11 and SAAP-13. The cytotoxicity of peptides towards human normal lung epithelial cells (BEAS-2B) was closely linked to their haemolytic activity, indicating that substituting lysine may mitigate the cytotoxic effects of SAAP-148. Additionally, the arrangement of positively charged residues in the peptides significantly influenced its antimicrobial activity. Our findings suggest that the positioning of a positively charged residue has a significant impact on the biophysical properties of the peptide. Additionally, the substitution of lysine at different positions demonstrates an influence on the anti-lipopolysaccharide (anti-LPS) activity of SAAP-148. These discoveries provide valuable insights for the design and optimization of antimicrobial peptides, which will be advantageous for the future development of antimicrobial agents. Full article
(This article belongs to the Special Issue Structure, Function and Dynamics in Proteins: 2nd Edition)
Show Figures

Figure 1

Figure 1
<p>Helical wheel projections of SAAP-148 and its analogues generated using HeliQuest [<a href="#B24-ijms-25-11776" class="html-bibr">24</a>]. By default, the output presents the polar, positively charged amino acids as blue circles; the polar, uncharged amino acids as pink circles; the hydrophobic residues as green; and the most hydrophobic residues as yellow circles. The red arrow indicates the mutated residue.</p>
Full article ">Figure 2
<p>The hemolytic activity of SAAP-148 and its derivatives on human erythrocytes.</p>
Full article ">Figure 3
<p>The cytotoxic effects of SAAP-148 and its analogues on BEAS-2B cells.</p>
Full article ">Figure 4
<p>The effect of SAAP-148 and its analogues on the inhibition of LPS-induced NO in mouse RAW264.7 macrophages. The red-shaded column on the left-hand side of the figure presents the NO inhibition rate of SAAP-148 and its analogues. The blue-shaded column on the right-hand side of the figure presents the toxicity of SAAP-148 and its analogues.</p>
Full article ">
7 pages, 325 KiB  
Case Report
Acute Kidney Injury and Post-Artesunate Delayed Haemolysis in the Course of Plasmodium falciparum Malaria
by Alicja Kubanek, Małgorzata Sulima, Aleksandra Szydłowska, Katarzyna Sikorska and Marcin Renke
Pathogens 2024, 13(10), 851; https://doi.org/10.3390/pathogens13100851 - 30 Sep 2024
Viewed by 1096
Abstract
Malaria is a major international public health problem. The risk of acquiring malaria varies depending on the intensity of transmission and adherence to mosquito precautions and prophylaxis recommendations. Severe malaria can cause significant multiorgan dysfunction, including acute kidney injury (AKI). Intravenous artesunate is [...] Read more.
Malaria is a major international public health problem. The risk of acquiring malaria varies depending on the intensity of transmission and adherence to mosquito precautions and prophylaxis recommendations. Severe malaria can cause significant multiorgan dysfunction, including acute kidney injury (AKI). Intravenous artesunate is the treatment of choice for severe malaria in non-endemic areas. One of the possible events connected with the lifesaving effects of artemisins is post-artesunate haemolysis (PADH), which may be potentially dangerous and under-recognised. We present a case of a seafarer with severe Plasmodium falciparum malaria complicated with AKI and PADH, with a good response to steroid treatment. This case highlights the need for malaria prophylaxis in business travellers, e.g., seafarers to malara-endemic regions, and close supervision of patients with malaria even after the completion of antimalarial treatment due to the possibility of late complications. Full article
(This article belongs to the Special Issue Parasitic Diseases in the Contemporary World)
Show Figures

Figure 1

Figure 1
<p>Haemoglobin and creatinine levels in the course of infection.</p>
Full article ">
11 pages, 4485 KiB  
Article
Characterization of Exopolysaccharides Isolated from Donkey Milk and Its Biological Safety for Skincare Applications
by Chiara La Torre, Pierluigi Plastina, Diana Marisol Abrego-Guandique, Paolino Caputo, Cesare Oliviero Rossi, Giorgia Francesca Saraceno, Maria Cristina Caroleo, Erika Cione and Alessia Fazio
Polysaccharides 2024, 5(3), 493-503; https://doi.org/10.3390/polysaccharides5030031 - 12 Sep 2024
Cited by 1 | Viewed by 999
Abstract
Kefiran is a heteropolysaccharide that is considered a postbiotic and is obtained by kefir grains fermented in cow’s milk, while little is known about the donkey milk (DM) variety. Postbiotics are recognised as having important human health benefits that are very similar to [...] Read more.
Kefiran is a heteropolysaccharide that is considered a postbiotic and is obtained by kefir grains fermented in cow’s milk, while little is known about the donkey milk (DM) variety. Postbiotics are recognised as having important human health benefits that are very similar to probiotics but without the negative effects associated with their ingestion. Donkey is a monogastric animal, as are humans, and when used as an alternative food for infants who suffer from cow milk protein allergies, DM could therefore display more biocompatibility. In this study, the DM kefiran was extracted by ultrasound from kefir grains cultured in donkey milk and fully characterized for its structural and physicochemical properties by Fourier-transform infrared spectroscopy (FT-IR), High-Performance Liquid Chromatography- Refractive Index (HPLC-RI), Scanning electron microscope (SEM), Differential Scanning Calorimeters (DSC) and rheological analyses. In addition, tests were conducted on keratinocytes cell lines and human red blood cells to assess the nontoxicity and haemolysis degree of the polymer. The extraction yield of the DM kefiran was 6.5 ± 0.15%. The FT-IR analysis confirmed the structure of the polysaccharide by showing that the stretching of the C-O-C and C-O bonds in the ring, which formed two bands at 1157 and 1071 cm−1, respectively, and the anomeric band at 896 cm−1 indicates the β configuration and vibrational modes of glucose and galactose. Results were confirmed by HPLC-RI analysis indicating that the ratio glucose/galactose was 1:0.87. Furthermore, the SEM analysis showed a porous and homogeneous structure. The rheological analysis confirmed the pseudoplastic nature of the polymer, while the DSC analysis highlighted excellent thermal resistance (324 °C). Finally, DM kefiran was revealed to have biologically acceptable toxicity, showing a haemolytic activity of less than 2% when using fresh human red blood cells and showing no cytotoxicity on human keratinocytes. Therefore, kefiran obtained by DM shows an excellent biocompatibility, establishing it as a promising polymer for bioengineering human tissue for regenerative applications. Full article
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Fourier-transform infrared spectroscopy spectra of kefiran from DM.</p>
Full article ">Figure 2
<p>Intensity of refraction index signals (µV) versus retention times (min) after HPLC separation of monosaccharide standards (glucose 15.9 min, galactose 16.9 min, black and red lines respectively) and kefiran from DM before and after hydrolyzation (blue and pink line respectively).</p>
Full article ">Figure 3
<p>Differential scanning calorimetry spectra of exopolysaccharide from DM, showing three endothermic peaks at 112.4 ± 9.5, 280.6 ± 0.7 and 324.2 ± 3.19 °C.</p>
Full article ">Figure 4
<p>Rheology results of kefiran from DM at 0.1, 1, 10 and 100 s<sup>−1</sup>.</p>
Full article ">Figure 5
<p>Scanning electron microscopy was used to study the surface morphologies. The kefiran from donkey milk was analysed at three magnifications equal to 100×, 1000× and 10,000×, with scales of 1.0 mm, 100.0 µm and 10.0 µm, respectively.</p>
Full article ">Figure 6
<p>Cytotoxicity of kefiran polymers at three concentrations (50, 100 and 200 µg/mL) on the HaCat cell line.</p>
Full article ">
12 pages, 2268 KiB  
Article
Moving toward Individual Treatment Goals with Pegcetacoplan in Patients with PNH and Impaired Bone Marrow Function
by Jeff Szer, Jens Panse, Austin Kulasekararaj, Monika Oliver, Bruno Fattizzo, Jun-ichi Nishimura, Regina Horneff, Johan Szamosi and Régis Peffault de Latour
Int. J. Mol. Sci. 2024, 25(16), 8591; https://doi.org/10.3390/ijms25168591 - 6 Aug 2024
Cited by 1 | Viewed by 1515
Abstract
Paroxysmal nocturnal haemoglobinuria (PNH) is a rare, potentially life-threatening haematological disease characterised by chronic complement-mediated haemolysis with multiple clinical consequences that impair quality of life. This post hoc analysis assessed haematological and clinical responses to the first targeted complement C3 inhibitor pegcetacoplan in [...] Read more.
Paroxysmal nocturnal haemoglobinuria (PNH) is a rare, potentially life-threatening haematological disease characterised by chronic complement-mediated haemolysis with multiple clinical consequences that impair quality of life. This post hoc analysis assessed haematological and clinical responses to the first targeted complement C3 inhibitor pegcetacoplan in patients with PNH and impaired bone marrow function in the PEGASUS (NCT03500549) and PRINCE (NCT04085601) studies. For patients with impaired bone marrow function, defined herein as haemoglobin <10 g/dL and absolute neutrophil count <1.5 × 109 cells/L, normalisation of the parameters may be difficult. Indeed, 20% and 43% had normalised haemoglobin in PEGASUS and PRINCE, respectively; 60% and 57% had normalised LDH, and 40% and 29% had normalised fatigue scores. A new set of parameters was applied using changes associated with clinically meaningful improvements, namely an increase in haemoglobin to ≥2 g/dL above baseline, decrease in LDH to ≤1.5× the upper limit of normal, and an increase in fatigue scores to ≥5 points above baseline. With these new parameters, 40% and 71% of PEGASUS and PRINCE patients had improved haemoglobin; 60% and 71% had an improvement in LDH, and 60% and 43% had an improvement in fatigue scores. Thus, even patients with impaired bone marrow function may achieve clinically meaningful improvements with pegcetacoplan. Full article
Show Figures

Figure 1

Figure 1
<p>Mean haematological parameters over time for pegcetacoplan-treated PNH patients with and without impaired bone marrow function in the PEGASUS study. Patient numbers at week 16 and week 48 are as follows in the group of patients with impaired bone marrow function at baseline: haemoglobin, LDH and ARC, 3 patients each; platelets and neutrophils, 4 and 2 patients, respectively. Patient numbers at week 16 and week 48 are as follows in the group of patients without impaired bone marrow function at baseline: haemoglobin, 32 and 25 patients, respectively; LDH, 31 and 25 patients, respectively; ARC, 30 and 24 patients, respectively; platelets, 31 and 22 patients, respectively; neutrophils, 30 and 22 patients, respectively. ARC, absolute reticulocyte count; Hb, haemoglobin; LDH, lactate dehydrogenase; SE, standard error.</p>
Full article ">Figure 2
<p>Mean haematological parameters over time for pegcetacoplan-treated PNH patients with and without impaired bone marrow function in the PRINCE study. Patient numbers at week 26 are as follows in the group of patients with impaired bone marrow function at baseline: haemoglobin, LDH, ARC, platelets, neutrophils, 5 patients each. Patient numbers at week 26 are as follows in the group of patients without impaired bone marrow function at baseline: haemoglobin, 24 patients; LDH, 24 patients; ARC, 21 patients; platelets, 25 patients; neutrophils, 20 patients. ARC, absolute reticulocyte count; Hb, haemoglobin; LDH, lactate dehydrogenase; SE, standard error.</p>
Full article ">Figure 3
<p>Proportion of pegcetacoplan-treated PNH patients with and without impaired bone marrow function reaching clinically meaningful treatment outcomes vs. normalisation. CFB, change from baseline; FACIT, Functional Assessment of Chronic Illness Therapy; LDH, lactate dehydrogenase; LLN, lower limit of normal; ULN, upper limit of normal.</p>
Full article ">Figure 4
<p>(<b>A</b>) PEGASUS [<a href="#B14-ijms-25-08591" class="html-bibr">14</a>,<a href="#B15-ijms-25-08591" class="html-bibr">15</a>] and (<b>B</b>) PRINCE [<a href="#B11-ijms-25-08591" class="html-bibr">11</a>] study designs. * Pegcetacoplan run-in periods in PEGASUS: (1) before randomisation, for both treatment groups; and (2) at start of open-label period, for the patients randomised to the eculizumab monotherapy group during the randomised controlled period. <sup>†</sup> Haemoglobin levels: LLN males, &lt;13.6 g/dL; LLN females, &lt;12.0 g/dL; LDH, 1.5 × ULN ≥339 U/L. <sup>‡</sup> All patients screened in PRINCE had never received a complement inhibitor at any point. C5i, complement 5 inhibitor; LDH, lactate dehydrogenase; LLN, lower limit of normal; PNH, paroxysmal nocturnal haemoglobinuria; SC, subcutaneous; ULN, upper limit of normal.</p>
Full article ">
19 pages, 6699 KiB  
Article
Thermally Stabilised Poly(vinyl alcohol) Nanofibrous Materials Produced by Scalable Electrospinning: Applications in Tissue Engineering
by W. Joseph A. Homer, Maxim Lisnenko, Sarka Hauzerova, Bohdana Heczkova, Adrian C. Gardner, Eva K. Kostakova, Paul D. Topham, Vera Jencova and Eirini Theodosiou
Polymers 2024, 16(14), 2079; https://doi.org/10.3390/polym16142079 - 21 Jul 2024
Viewed by 1098
Abstract
Electrospinning is a widely employed manufacturing platform for tissue engineering applications because it produces structures that closely mimic the extracellular matrix. Herein, we demonstrate the potential of poly(vinyl alcohol) (PVA) electrospun nanofibers as scaffolds for tissue engineering. Nanofibers were created by needleless direct [...] Read more.
Electrospinning is a widely employed manufacturing platform for tissue engineering applications because it produces structures that closely mimic the extracellular matrix. Herein, we demonstrate the potential of poly(vinyl alcohol) (PVA) electrospun nanofibers as scaffolds for tissue engineering. Nanofibers were created by needleless direct current electrospinning from PVA with two different degrees of hydrolysis (DH), namely 98% and 99% and subsequently heat treated at 180 °C for up to 16 h to render them insoluble in aqueous environments without the use of toxic cross-linking agents. Despite the small differences in the PVA chemical structure, the changes in the material properties were substantial. The higher degree of hydrolysis resulted in non-woven supports with thinner fibres (285 ± 81 nm c.f. 399 ± 153 nm) that were mechanically stronger by 62% (±11%) and almost twice as more crystalline than those from 98% hydrolysed PVA. Although prolonged heat treatment (16 h) did not influence fibre morphology, it reduced the crystallinity and tensile strength for both sets of materials. All samples demonstrated a lack or very low degree of haemolysis (<5%), and there were no notable changes in their anticoagulant activity (≤3%). Thrombus formation, on the other hand, increased by 82% (±18%) for the 98% hydrolysed samples and by 71% (±10%) for the 99% hydrolysed samples, with heat treatment up to 16 h, as a direct consequence of the preservation of the fibrous morphology. 3T3 mouse fibroblasts showed the best proliferation on scaffolds that were thermally stabilised for 4 and 8 h. Overall these scaffolds show potential as ‘greener’ alternatives to other electrospun tissue engineering materials, especially in cases where they may be used as delivery vectors for heat tolerant additives. Full article
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Chemical structure of PVA, where the left monomer unit is PVA, at a relative molar abundance of <span class="html-italic">n</span>%, and the right monomer unit shows a residual acetate group of relative molar abundance of <span class="html-italic">m</span>%.</p>
Full article ">Figure 2
<p>SEM images of 98% and 99% hydrolysed electrospun PVA following heat treatment at 180 °C for 0, 1, 4, 8 and 16 h. Scale bars: 10 µm.</p>
Full article ">Figure 3
<p>Box and whisker plot of fibre diameters for 98% and 99% hydrolysed PVA needleless electrospun mats heat treated for 0–16 h. Key: 98% (white); 99% (grey). Full histograms are available in <a href="#app1-polymers-16-02079" class="html-app">Figure S1</a>.</p>
Full article ">Figure 4
<p>FT-IR Spectra of two sample series of 98% (<b>left</b>) and 99% (<b>right</b>) DH PVA produced by needleless electrospinning with heat treatment time points indicated on the offset spectra.</p>
Full article ">Figure 5
<p>XRD spectra of 98% (<b>left</b>) and 99% (<b>right</b>) DH PVA materials produced by DC electrospinning. Key: 0 h (light blue); 1 h (orange); 4 h (grey); 8 h (yellow); 16 h (dark blue).</p>
Full article ">Figure 6
<p>Tensile performance of samples produced from 98% and 99% hydrolysed PVA electrospun mats after thermal stabilisation. (n = 3). Key: 98% (white); 99% (grey). Representative stress–strain curves can be found in <a href="#app1-polymers-16-02079" class="html-app">Figure S2</a>. ns <span class="html-italic">p</span> &gt; 0.05, * <span class="html-italic">p</span> ≤ 0.05, ** <span class="html-italic">p</span> ≤ 0.01, **** <span class="html-italic">p</span> ≤ 0.0001.</p>
Full article ">Figure 7
<p>Sessile drop contact angle data for films produced from 98% and 99% hydrolysed PVA after thermal stabilisation. (n = 3). Key: 98% (white); 99% (grey). **** <span class="html-italic">p</span> ≤ 0.0001.</p>
Full article ">Figure 8
<p>Cell viability results of 98% (left-hand side) and 99% (right-hand side) PVA nanofibrous mats after heat treatment at time points of 1, 3 and 7 days after seeding, with absorbance measured at 450 nm. Key: positive control/PC—well plate plastic (light blue); 1 h (orange); 4 h (grey); 8 h (yellow); 16 h (dark blue). (n = 4). * <span class="html-italic">p</span> ≤ 0.05, ** <span class="html-italic">p</span> ≤ 0.01, *** <span class="html-italic">p</span> ≤ 0.001, **** <span class="html-italic">p</span> ≤ 0.0001.</p>
Full article ">Figure 9
<p>Representative SEM images of 3T3 cells on 98% and 99% DH PVA mats produced by electrospinning 7 days after cell seeding. Scale bars: 20 µm.</p>
Full article ">Figure 10
<p>Cell viability results of thrombocyte activity on 98% and 99% DH PVA mats following heat treatment and 2 h exposure to TRS, with absorbance measured at 450 nm. Key: positive control/PC—well plate plastic (cross-hatched); 98% (white); 99% (grey). * <span class="html-italic">p</span> ≤ 0.05, ** <span class="html-italic">p</span> ≤ 0.01, *** <span class="html-italic">p</span> ≤ 0.001, **** <span class="html-italic">p</span> ≤ 0.0001.</p>
Full article ">Figure 11
<p>Representative SEM images of activated platelets on 98% and 99% DH PVA mats produced by needleless electrospinning. Scale bars: 10 µm.</p>
Full article ">Figure 12
<p>Box and whisker plots of APTT (<b>left</b>) and PT (<b>right</b>) coagulation tests of nanofibrous mats produced from 98% and 99% hydrolysed PVA after heat treatment. Key: 98% (white); 99% (grey). Control/NC—clinical plasma in isolation (n = 5).</p>
Full article ">Figure 13
<p>Haemolysis percentage of red blood cells after incubation with nanofibrous materials. Absorbance at 570 nm measures haemoglobin released in the solution after centrifugal separation of erythrocytes. Absorbance values for controls were measured for distilled water (PC) and PBS (NC) and then all values were normalised against the positive control. The left-hand-side graph excludes PC to allow focusing on the area of interest, while the right-hand-side graph has the PC included. Dashed line indicates 5% haemolysis. Key: 98% DH (white); 99% DH (grey) (n = 5).</p>
Full article ">Figure 14
<p>SEM images of nanofibrous materials produced by needless electrospinning after fixing of red blood cells. Scale bars: 10 µm.</p>
Full article ">
14 pages, 3725 KiB  
Article
Guanidinium Chloride-Induced Haemolysis Assay to Measure New Permeation Pathway Functionality in Rodent Malaria Plasmodium berghei
by Mitchell L. Trickey, Natalie A. Counihan, Joyanta K. Modak and Tania F. de Koning-Ward
Biomolecules 2024, 14(7), 781; https://doi.org/10.3390/biom14070781 - 30 Jun 2024
Viewed by 1144
Abstract
Parasite-derived new permeation pathways (NPPs) expressed at the red blood cell (RBC) membrane enable Plasmodium parasites to take up nutrients from the plasma to facilitate their survival. Thus, NPPs represent a potential novel therapeutic target for malaria. The putative channel component of the [...] Read more.
Parasite-derived new permeation pathways (NPPs) expressed at the red blood cell (RBC) membrane enable Plasmodium parasites to take up nutrients from the plasma to facilitate their survival. Thus, NPPs represent a potential novel therapeutic target for malaria. The putative channel component of the NPP in the human malaria parasite P. falciparum is encoded by mutually exclusively expressed clag3.1/3.2 genes. Complicating the study of the essentiality of these genes to the NPP is the addition of three clag paralogs whose contribution to the P. falciparum channel is uncertain. Rodent malaria P. berghei contains only two clag genes, and thus studies of P. berghei clag genes could significantly aid in dissecting their overall contribution to NPP activity. Previous methods for determining NPP activity in a rodent model have utilised flux-based assays of radioisotope-labelled substrates or patch clamping. This study aimed to ratify a streamlined haemolysis assay capable of assessing the functionality of P. berghei NPPs. Several isotonic lysis solutions were tested for their ability to preferentially lyse infected RBCs (iRBCs), leaving uninfected RBCs (uRBCs) intact. The osmotic lysis assay was optimised and validated in the presence of NPP inhibitors to demonstrate the uptake of the lysis solution via the NPPs. Guanidinium chloride proved to be the most efficient reagent to use in an osmotic lysis assay to establish NPP functionality. Furthermore, following treatment with guanidinium chloride, ring-stage parasites could develop into trophozoites and schizonts, potentially enabling use of guanidinium chloride for parasite synchronisation. This haemolysis assay will be useful for further investigation of NPPs in P. berghei and could assist in validating its protein constituents. Full article
Show Figures

Figure 1

Figure 1
<p>Osmotic lysis of <span class="html-italic">P. falciparum</span>-infected RBCs. Ring-stage parasites and uRBCs do not possess NPPs and thus remain intact following sorbitol lysis assay, as the sorbitol solution is unable to cross RBC membrane via endogenous channels. Late-stage parasites (trophozoite and schizont) possessing NPPs import an isotonic sorbitol solution into the cell, and this is accompanied by the osmotic influx of water. The iRBCs subsequently swell and burst, releasing haemoglobin and other cellular contents into the solution.</p>
Full article ">Figure 2
<p>Sorbitol-mediated lysis of uninfected and <span class="html-italic">P. berghei</span>-infected rodent RBCs. Lysis assays (n = 3) were performed by incubating iRBCs (10% parasitemia) and uRBCs (negative control) in 280 mM sorbitol buffered in 20 mM HEPES, pH 7.4, at the indicated temperatures for 10 min. The percentage lysis was calculated relative to lysis with saponin (100% lysis). No significant (ns) difference was observed between the infected and uninfected samples at any of the indicated temperatures.</p>
Full article ">Figure 3
<p>Lysis of uninfected and <span class="html-italic">P. berghei</span>-infected rodent RBCs using different isotonic solutions at varying temperatures. Lysis assays (n = 3) were performed on iRBCs (10% parasitemia) and uRBCs (negative control) using either guanidinium chloride (<b>a</b>), L-isoleucine (<b>b</b>), L-alanine (<b>c</b>), or D-alanine (<b>d</b>) at the specified temperatures, and the percentage of RBC lysis after 10 min was calculated relative to lysis with saponin (100% lysis) (*** <span class="html-italic">p</span> ≤ 0.001, **** <span class="html-italic">p</span> ≤ 0.0001).</p>
Full article ">Figure 4
<p>Lysis of <span class="html-italic">P. berghei</span>-infected and uninfected rodent RBCs at varying incubation times. Lysis assays (n = 3) were conducted on iRBC (10% parasitemia) and uRBC samples (negative control) using either guanidinium chloride (<b>a</b>), L-isoleucine (<b>b</b>), or L-alanine (<b>c</b>). The assays were carried out at 37 °C for the specified times and the percentage lysis was calculated relative to saponin (100% lysis) (** <span class="html-italic">p</span> ≤ 0.01, **** <span class="html-italic">p</span> ≤ 0.0001).</p>
Full article ">Figure 5
<p>Lysis of <span class="html-italic">P. berghei</span>- and <span class="html-italic">P. falciparum</span>-infected and uninfected RBCs using NPP inhibitors furosemide and NPPB. Lysis assays (n = 3) were conducted on iRBCs (10% parasitemia) and uRBCs (negative control) from <span class="html-italic">P. falciparum</span> (<b>a</b>,<b>b</b>) and <span class="html-italic">P. berghei</span> (<b>c</b>,<b>d</b>) using either sorbitol (<b>a</b>), guanidinium chloride (<b>b</b>,<b>c</b>), or L-alanine (<b>d</b>). The assays were carried out at 37 °C for 10 min in the presence and absence of 200 μM furosemide, 200 μM 5-nitro-2-(3-phenylpropylamino) benzoic acid (NPPB) or DMSO as a negative (vehicle) control, and the percentage lysis was calculated relative to saponin (100% lysis) (** <span class="html-italic">p</span> ≤ 0.01, **** <span class="html-italic">p</span> ≤ 0.0001).</p>
Full article ">Figure 6
<p>Lysis of synchronous populations of <span class="html-italic">P. berghei</span>-infected and uninfected RBC. Lysis assays (n = 4) were conducted on iRBC (average parasitemia 1.65%, ±0.32%) and uRBC samples (negative control) using guanidinium chloride. The assays were carried out at 37 °C for 10 min and the percentage lysis was calculated relative to saponin (100% lysis). Populations of ring and trophozoite parasites were used in the assay, where trophozoites were matured from ring stages in vitro (**** <span class="html-italic">p</span> ≤ 0.0001).</p>
Full article ">Figure 7
<p>Survival assay following guanidinium chloride lysis assay. (<b>a</b>) Ring-stage <span class="html-italic">P. berghei</span> parasites 0-4 h prior to resuspension in guanidinium chloride. (<b>b</b>) Ring-stage parasites following resuspension in guanidinium chloride. (<b>c</b>) Trophozoite-stage parasites ~16 h later. (<b>d</b>) Schizont-stage parasites ~24 h following guanidinium chloride lysis assay (n = 3).</p>
Full article ">
14 pages, 543 KiB  
Article
Mild Systemic Inflammation Increases Erythrocyte Fragility
by Charlotte M. Stuart, Carmen Jacob, Aravinthan Varatharaj, Sarah Howard, Joe K. Chouhan, Jessica L. Teeling and Ian Galea
Int. J. Mol. Sci. 2024, 25(13), 7027; https://doi.org/10.3390/ijms25137027 - 27 Jun 2024
Cited by 2 | Viewed by 1958
Abstract
There is growing evidence that inflammation impairs erythrocyte structure and function. We assessed the impact of mild systemic inflammation on erythrocyte fragility in three different settings. In order to investigate causation, erythrocyte osmotic fragility was measured in mice challenged with a live attenuated [...] Read more.
There is growing evidence that inflammation impairs erythrocyte structure and function. We assessed the impact of mild systemic inflammation on erythrocyte fragility in three different settings. In order to investigate causation, erythrocyte osmotic fragility was measured in mice challenged with a live attenuated bacterial strain to induce low-grade systemic inflammation; a significant increase in erythrocyte osmotic fragility was observed. To gather evidence that systemic inflammation is associated with erythrocyte fragility in humans, two observational studies were conducted. First, using a retrospective study design, the relationship between reticulocyte-based surrogate markers of haemolysis and high-sensitivity C-reactive protein was investigated in 9292 healthy participants of the UK Biobank project. Secondly, we prospectively assessed the relationship between systemic inflammation (measured by the urinary neopterin/creatinine ratio) and erythrocyte osmotic fragility in a mixed population (n = 54) of healthy volunteers and individuals with long-term medical conditions. Both human studies were in keeping with a relationship between inflammation and erythrocyte fragility. Taken together, we conclude that mild systemic inflammation increases erythrocyte fragility and may contribute to haemolysis. Further research is needed to assess the molecular underpinnings of this pathway and the clinical implications in inflammatory conditions. Full article
(This article belongs to the Topic Inflammation: The Cause of all Diseases 2.0)
Show Figures

Figure 1

Figure 1
<p>A mild systemic inflammatory stimulus increases erythrocyte fragility in mice. C57BL/6 mice received an intraperitoneal challenge with attenuated <span class="html-italic">Salmonella typhimurium</span> vaccine strain SL3261, and their erythrocyte fragility, measured in an ex vivo osmotic fragility assay, was compared at three time points (n = 3 each time point) versus naive mice (n = 3). (<b>a</b>) Daily weight of mice receiving the bacterial challenge. (<b>b</b>) Erythrocyte fragility as quantified by the median corpuscular fragility (MCF) (n = 3 each time point). Data are shown as mean ± SD.</p>
Full article ">
26 pages, 5723 KiB  
Article
In Vitro Screening of Ecotoxic and Cytotoxic Activities of Ailanthus altissima Leaf Extract against Target and Non-Target Plant and Animal Cells
by Maria Denisa Cocîrlea, Natalia Simionescu, Anca Roxana Petrovici, Mihaela Silion, Barbara Biondi, Luana Lastella and Simona Oancea
Int. J. Mol. Sci. 2024, 25(11), 5653; https://doi.org/10.3390/ijms25115653 - 22 May 2024
Cited by 2 | Viewed by 1292
Abstract
Ailanthus altissima, an invasive plant species, exhibits pharmacological properties, but also some allergic effects on humans. This study aimed to evaluate the potential toxicity of A. altissima leaves, using a complex approach towards different organisms. The ecotoxic impact of a crude extract [...] Read more.
Ailanthus altissima, an invasive plant species, exhibits pharmacological properties, but also some allergic effects on humans. This study aimed to evaluate the potential toxicity of A. altissima leaves, using a complex approach towards different organisms. The ecotoxic impact of a crude extract was investigated on seeds germination and brine shrimp lethality. Cytotoxicity was studied in vitro using non-target (haemolysis, liposomal model, fibroblast), and target (cancer cells) assays. Leaf extract at 1000 µg/mL significantly inhibited wheat and tomato germination, while no significant effects were found on parsley germination. A slight stimulatory effect on wheat and tomato germination was found at 125 µg/mL. In a brine shrimp-test, the extract showed a low toxicity at 24 h post-exposure (LC50 = 951.04 ± 28.26 μg/mL), the toxic effects increasing with the exposure time and extract concentration. Leaf extract caused low hematotoxicity. The extract was biocompatible with human gingival fibroblasts. No anti-proliferative effect was found within the concentration range of 10–500 µg/mL on malignant melanoma (MeWo) and hepatocellular carcinoma (HepG2). In a liposomal model-test, the extract proved to possess low capability to alter the eukaryotic cell-mimicking membranes within the tested concentration range. Given the low to moderate toxicity on tested organisms/cells, the A. altissima autumn leaves may find useful applications. Full article
(This article belongs to the Special Issue Investigation of Natural Products as Sources of Bioactive Molecules)
Show Figures

Figure 1

Figure 1
<p>The comparative HPLC-DAD chromatograms of polyphenolic compounds; (<b>A</b>)—Standards: 1—Gallic acid, 2—Protocatechuic acid, 3—Catechin, 4—Vanillic acid, 5—Epicatechin, 6—Caffeic acid, 7—Syringic acid, 8—Rutin, 9—Ferulic acid, 10—<span class="html-italic">p</span>-Coumaric acid, 11—Hesperidin, 12—Rosmarinic acid, 13—Salicylic acid, 14—Quercetin, 15—Kaempferol; (<b>B</b>)—crude leaf extract.</p>
Full article ">Figure 2
<p>Boxplot representation of the measured/calculated wheat germination indices, according to extract concentration.</p>
Full article ">Figure 3
<p>Correlation plot of the Spearman’s correlation coefficients between the measured/calculated wheat germination indices.</p>
Full article ">Figure 4
<p>Boxplot representation of the measured /calculated tomato germination indices, according to the extract concentration.</p>
Full article ">Figure 5
<p>Correlation plot of the Spearman’s correlation coefficients between the measured/calculated tomato seed germination indices.</p>
Full article ">Figure 6
<p>Boxplot representation of the measured/calculated parsley germination indices, according to the extract concentration.</p>
Full article ">Figure 7
<p>Correlation plot of the Spearman’s correlation coefficients between the measured/calculated parsley seed germination indices.</p>
Full article ">Figure 8
<p>Evolution of the cumulative mortality rate of <span class="html-italic">A. salina</span> larvae incubated with different concentrations of <span class="html-italic">A. altissima</span> leaf extract.</p>
Full article ">Figure 9
<p>Probit graph for LC<sub>50</sub> of <span class="html-italic">A. altissima</span> leaf extract against <span class="html-italic">A. salina</span>, after 24 h of exposure.</p>
Full article ">Figure 10
<p>Probit graph for LC<sub>50</sub> value of <span class="html-italic">A. altissima</span> leaf extract against <span class="html-italic">A. salina</span>, after 48 h of exposure.</p>
Full article ">Figure 11
<p>Hemolytic activity of leaf extract at different concentrations.</p>
Full article ">Figure 12
<p>Biocompatibility of <span class="html-italic">A. altissima</span> leaf extracts on human fibroblasts (HGF) after 24 h; data were represented as means ± standard error of the mean.</p>
Full article ">Figure 13
<p>Cytotoxicity of <span class="html-italic">A. altissima</span> leaf extracts on malignant melanoma (MeWo) and hepatocellular carcinoma (HepG2) cells after 24 h; data were represented as means ± standard error of the mean.</p>
Full article ">Figure 14
<p>Leaf extract-induced leakage of carboxifluorescein (CF) trapped within phosphatidylcholine/ cholesterol SUVs at 20 min for different [extract]/ [lipid] fractions.</p>
Full article ">
13 pages, 2235 KiB  
Article
Linalool Reduces Virulence and Tolerance to Adverse Conditions of Listeria monocytogenes
by Joel P. Dias, Fernanda C. Domingues and Susana Ferreira
Antibiotics 2024, 13(6), 474; https://doi.org/10.3390/antibiotics13060474 - 22 May 2024
Viewed by 1279
Abstract
Listeria monocytogenes, a foodborne pathogen causing listeriosis, poses substantial societal, economic, and public health challenges due to its resistance, persistence, and biofilm formation in the food industry. Exploring subinhibitory concentrations of compounds to target virulence inhibition and increase susceptibility to adverse conditions [...] Read more.
Listeria monocytogenes, a foodborne pathogen causing listeriosis, poses substantial societal, economic, and public health challenges due to its resistance, persistence, and biofilm formation in the food industry. Exploring subinhibitory concentrations of compounds to target virulence inhibition and increase susceptibility to adverse conditions presents a promising strategy to mitigate its impact of L. monocytogenes and unveils new potential applications. Thus, this study aims to explore the effect of linalool on virulence factors of L. monocytogenes and potential use in the reduction in its tolerance to stressful conditions. This action was analysed considering the use of two sub-inhibitory concentrations of linalool, 0.312 and 0.625 mg/mL. We found that even with the lowest tested concentrations, a 65% inhibition of violacein production by Chromobacterium violaceum, 55% inhibition in biofilm formation by L. monocytogenes and 62% reduction on haemolysis caused by this bacterium were observed. In addition to its impact on virulence factors, linalool diminished the tolerance to osmotic stress (up to 4.3 log reduction after 24 h with 12% NaCl), as well as to high (up to 3.8 log reduction after 15 min at 55 °C) and low temperatures (up to 4.6 log reduction after 84 days with 12% NaCl at 4 °C). Thus, this study paves the way to further investigation into the potential utilization of linalool to mitigate the threat posed by L. monocytogenes in the field of food safety and public health. Full article
Show Figures

Figure 1

Figure 1
<p>Growth curves for <span class="html-italic">L. monocytogenes</span> LMG 13305, incubated with 0.625 and 0.312 mg/mL of linalool, with growth and solvent controls. The results are presented as the mean ± standard deviation (SD). Asterisks represent significant differences to the growth control, * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, **** <span class="html-italic">p</span> &lt; 0.0001 between the assay and the growth control.</p>
Full article ">Figure 2
<p>Quorum-sensing inhibition, represented by violacein percentage inhibition (columns) and microbial density (OD<sub>600 nm</sub>) (●) by 0.625 and 0.312 mg/mL of linalool, 19.5 µg/mL of resveratrol used as positive control and 0.06% of DMSO as a solvent control. The results are presented as the mean ± standard error of the means (SEM). Asterisks represent significant differences, in comparison to the control * (<span class="html-italic">p</span> &lt; 0.05); ** (<span class="html-italic">p</span> &lt; 0.01); **** (<span class="html-italic">p</span> &lt; 0.0001).</p>
Full article ">Figure 3
<p>Inhibitory effect of 0.625 and 0.312 mg/mL of linalool in motility of <span class="html-italic">L. monocytogenes</span> LMG 13305, at 24, 48 and 72 h. The results are presented as the mean ± SD. ns (<span class="html-italic">p</span> &gt; 0.05); * (<span class="html-italic">p</span> &lt; 0.05); ** (<span class="html-italic">p</span> &lt; 0.01); *** (<span class="html-italic">p</span> &lt; 0.001); **** (<span class="html-italic">p</span> &lt; 0.0001).</p>
Full article ">Figure 4
<p>Inhibition of <span class="html-italic">L. monocytogenes</span> LMG 13305 biofilm formation by 0.625 and 0.312 mg/mL of linalool. The results are presented as the mean ± SEM. ns (<span class="html-italic">p</span> &gt; 0.05); **** (<span class="html-italic">p</span> &lt; 0.0001).</p>
Full article ">Figure 5
<p>Evaluation of the haemolysis caused by different concentrations of linalool in humans’ erythrocytes.</p>
Full article ">Figure 6
<p>Haemolysis of humans’ erythrocytes by pre-exposure of <span class="html-italic">L. monocytogenes</span> LMG 13305 with 0.625 mg/mL and 0.312 mg/mL concentration of linalool. The results are presented as the mean ± SEM. Asterisks represent significant differences, in comparison to the control ** (<span class="html-italic">p</span> &lt; 0.01); **** (<span class="html-italic">p</span> &lt; 0.0001).</p>
Full article ">Figure 7
<p>Evaluation of the effect of linalool on tolerance to: (<b>A</b>) osmotic stress (12% (<span class="html-italic">w</span>/<span class="html-italic">v</span>) NaCl); (<b>B</b>) high temperature (55 °C), (<b>C</b>) cold temperature (4 °C) and (<b>D</b>) cold temperature (4 °C) and 12% NaCl, by <span class="html-italic">L. monocytogenes</span> LMG 13305. The results are presented as the mean ± SD or SEM. Asterisks represent significant differences to the growth control, * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001, **** <span class="html-italic">p</span> &lt; 0.0001 between the assay and the control.</p>
Full article ">
34 pages, 7045 KiB  
Article
Romanian Bee Product Analysis: Chemical Composition, Antimicrobial Activity, and Molecular Docking Insights
by Silvia Pătruică, Suleiman Mukhtar Adeiza, Anca Hulea, Ersilia Alexa, Ileana Cocan, Dragos Moraru, Ilinca Imbrea, Doris Floares, Ioan Pet, Florin Imbrea and Diana Obiștioiu
Foods 2024, 13(10), 1455; https://doi.org/10.3390/foods13101455 - 8 May 2024
Cited by 4 | Viewed by 1475
Abstract
Bee products are considered true wonders of nature, used since ancient times, and studied even today for their various biological activities. In this study, we hypothesise that Romanian bee products from different origins (micro apiary products, lyophilised forms, commercial) exhibit distinct chemical compositions, [...] Read more.
Bee products are considered true wonders of nature, used since ancient times, and studied even today for their various biological activities. In this study, we hypothesise that Romanian bee products from different origins (micro apiary products, lyophilised forms, commercial) exhibit distinct chemical compositions, influencing their biological activities. An LC-MS analysis revealed varied polyphenolic content patterns, with cumaric acid, ferulic acid, rosmarinic acid, and quercitine identified in significant amounts across all samples. Primary anti-inflammatory evaluation phases, including the inhibition of haemolysis values and protein denaturation, unveiled a range of protective effects on red blood cells (RBC) and blood proteins, contingent upon the sample concentration. Antimicrobial activity assessments against 12 ATCC strains and 6 pathogenic isolates demonstrated varying efficacy, with propolis samples showing low efficacy, royal jelly forms displaying moderate effectiveness, and apilarnin forms exhibiting good inhibitory activity, mostly against Gram-positive bacteria. Notably, the lyophilised form emerged as the most promising sample, yielding the best results across the biological activities assessed. Furthermore, molecular docking was employed to elucidate the inhibitory potential of compounds identified from these bee products by targeting putative bacterial and fungal proteins. Results from the docking analysis showed rosmarinic and rutin exhibited strong binding energies and interactions with the putative antimicrobial proteins of bacteria (−9.7 kcal/mol to −7.6 kcal/mol) and fungi (−9.5 kcal/mol to −8.1 kcal/mol). The findings in this study support the use of bee products for antimicrobial purposes in a biologically active and eco-friendly proportion while providing valuable insights into their mechanism of action. Full article
(This article belongs to the Section Food Quality and Safety)
Show Figures

Figure 1

Figure 1
<p>The binding mode of some identified compounds in Tyrosyl-tRNA synthetase shows strong interactions with key amino acids.</p>
Full article ">Figure 1 Cont.
<p>The binding mode of some identified compounds in Tyrosyl-tRNA synthetase shows strong interactions with key amino acids.</p>
Full article ">Figure 2
<p>The binding mode of some identified compounds in peptide deformylase shows strong interactions with key amino acids.</p>
Full article ">Figure 3
<p>The binding mode of some identified compounds in DNA gyrase shows strong interactions with key amino acids.</p>
Full article ">Figure 3 Cont.
<p>The binding mode of some identified compounds in DNA gyrase shows strong interactions with key amino acids.</p>
Full article ">Figure 4
<p>The binding mode of some identified compounds in squalene epoxidase shows strong interactions with key amino acids.</p>
Full article ">Figure 4 Cont.
<p>The binding mode of some identified compounds in squalene epoxidase shows strong interactions with key amino acids.</p>
Full article ">Figure 5
<p>The binding mode of some identified compounds in 1,3-β-glucan synthase shows strong interactions with key amino acids.</p>
Full article ">Figure 5 Cont.
<p>The binding mode of some identified compounds in 1,3-β-glucan synthase shows strong interactions with key amino acids.</p>
Full article ">Figure 6
<p>The binding mode of some identified compounds into N-myristoyl transferase shows strong interactions with key amino acids.</p>
Full article ">
13 pages, 2584 KiB  
Article
Antibacterial, Anti-Biofilm, and Anti-Inflammatory Properties of Gelatin–Chitosan–Moringa-Biopolymer-Based Wound Dressings towards Staphylococcus aureus and Escherichia coli
by Salma Bessalah, Asim Faraz, Mohamed Dbara, Touhami Khorcheni, Mohamed Hammadi, Daniel Jesuwenu Ajose and Shamsaldeen Ibrahim Saeed
Pharmaceuticals 2024, 17(5), 545; https://doi.org/10.3390/ph17050545 - 23 Apr 2024
Viewed by 3092
Abstract
In contemporary times, the sustained aspiration of bioengineering and biomedical applications is the progressive advancement of materials characterized by biocompatibility and biodegradability. The investigation of the potential applications of polymers as natural and non-hazardous materials has placed significant emphasis on their physicochemical properties. [...] Read more.
In contemporary times, the sustained aspiration of bioengineering and biomedical applications is the progressive advancement of materials characterized by biocompatibility and biodegradability. The investigation of the potential applications of polymers as natural and non-hazardous materials has placed significant emphasis on their physicochemical properties. Thus, this study was designed to investigate the potential of gelatin–chitosan–moringa leaf extract (G–CH–M) as a novel biomaterial for biomedical applications. The wound-dressing G–CH–M biopolymer was synthesized and characterized. The blood haemolysis, anti-inflammatory, antioxidant, and antibacterial activities of the biopolymer were investigated against Gram-positive (Staphylococcus aureus) and Gram-negative (Escherichia coli) bacterial isolates. Our results showed that S. aureus swarming motility was drastically affected. However, the biopolymer had no significant effect on the swarming motility of E. coli. In addition, the biopolymer showed high antibacterial capacities, especially against S. aureus. Plasmid DNA was observed to be effectively protected from oxidative stresses by the biopolymer. Furthermore, the biopolymer exhibited greatly suppressed haemolysis (lower than 2%), notwithstanding the elevated concentration of 50 mg/mL. These results indicated that this novel biopolymer formulation could be further developed for wound care and contamination prevention. Full article
Show Figures

Figure 1

Figure 1
<p>The antibacterial activity evaluation of G–CH–M biopolymer with different concentrations (1 to 6: 20, 15, 10, 5, 2, and 1 mg/mL) against <span class="html-italic">E. coli</span> and <span class="html-italic">S. aureus</span> using agar diffusion in comparison with ampicillin as a positive control (+).</p>
Full article ">Figure 2
<p>The antibacterial activity of G–CH–M biopolymer at different concentrations against (<b>A</b>): <span class="html-italic">E. coli</span> and (<b>B</b>): <span class="html-italic">S</span>. <span class="html-italic">aureus</span> using the liquid medium microdilution method. Error bars represent standard deviation of triplicates.</p>
Full article ">Figure 3
<p>Effects of G–CH–M biopolymer on biofilm formation of <span class="html-italic">S. aureus</span> and <span class="html-italic">E. coli</span> after 24 h of incubation. Error bars represent standard deviation of triplicates.</p>
Full article ">Figure 4
<p>The motility of <span class="html-italic">Staphylococcus aureus</span> and <span class="html-italic">Escherichia coli</span> ante (1) and post (2) biopolymer treatment for 18 h.</p>
Full article ">Figure 5
<p>DPPH scavenging activity of G–CH–M biopolymer at different concentrations in comparison with biopolymer without moringa extract (control). Error bars represent standard deviation of triplicates.</p>
Full article ">Figure 6
<p>Ferrous chelating activity of G–CH–M biopolymer at different concentrations in comparison with biopolymer without moringa extract (control). Error bars represent standard deviation of triplicates.</p>
Full article ">Figure 7
<p>Protective effect of biopolymer on plasmid DNA nicking caused by hydroxyl radicals. Lane (1) native pHEN4 DNA; Lane (2) DNA plasmid + Fenton’s reagent; Lane (3) native pHEN4 DNA+ biopolymer Fenton’s reagent. Where form I, form II, and form III designed supercoiled form, nicked circular form, and linear form of plasmid, respectively.</p>
Full article ">Figure 8
<p>Effect of G–CH–M biopolymer on BSA denaturation. Error bars represent standard deviation of triplicates.</p>
Full article ">Figure 9
<p>Haemolysis ratios of RBCs treated with different concentrations of G–CH–M biopolymer at 37 °C for 3 h.</p>
Full article ">
Back to TopTop